Eugene Zhou

Eugene Zhou is a Senior Associate at Amgen, specializing in clinical and regulatory development for Inflammation assets, and a Venture Associate at Next Sequence®, focusing on techbio startups. Previously, Eugene worked as an Innovation Scout at Halo and as a Private Equity Associate Intern at Technology Capital Partners, where strategic M&A opportunities were identified to foster growth. As an Investment Associate with the USC Marshall Venture Fund, Eugene conducted due diligence on various startups and analyzed market trends for AI/ML infrastructure. Additional experience includes project management at ChromaCode, leading cross-functional teams in the development of assays, and research roles at the University of Southern California, EyeMedics, and PAREXEL. Eugene holds multiple degrees, including an MBA and a PhD in Clinical Experimental Therapeutics from USC.